Search results

Showing 1 – 50 of 60 results.
Curated

Arrestee Drug Abuse Monitoring Program II in the United States, 2007 (ICPSR 25821)

Released/updated on: 2010-01-28
Geographic coverage: North Carolina, Oregon, District of Columbia, Charlotte, Sacramento, Indiana, United States, Chicago, Minnesota, California, New York (state), New York City, Minneapolis, Atlanta, Illinois, Colorado, Portland (Oregon), Denver, Georgia, Indianapolis
Time period: 2007-04-01--2007-09-01
The Arrestee Drug Abuse Monitoring (ADAM) II program was designed to monitor trends in drug use among arrested populations in key urban areas across the United States. The first ADAM data collection was instituted in 2000 as a replacement for the Drug Use Forecasting program (DUF), which employed a non-scientific sampling procedure to select primarily felony arrestees in 23 urban areas throughout the country. The year 2000 revision of ADAM instituted a representative sampling strategy among booked male arrestees in an expanded network of 35 sites. The program was suspended by the National Institute of Justice in 2003 and restarted in 2007 with funding from the Office of National Drug Control Policy (ONDCP). With ADAM II, the ONDCP and Abt Associates have initiated a new data collection that replicates the ADAM methodology in order to obtain data comparable to previously established trends. ADAM II implemented two quarters of data collection in ten sentinel ADAM sites to revive monitoring drug trends, with a particular focus on obtaining valid and reliable information on methamphetamine use. A total of 8,296 arrestees were interviewed during the second and third quarters of 2007. Participation was voluntary and confidential, and the procedures included a personal interview (lasting approximately 20 minutes) and collection of a urine specimen. The Arrestee Drug Abuse Monitoring (ADAM) II survey collected data about drug use, drug and alcohol dependency and treatment, and drug market participation among booked male arrestees within 48 hours of arrest. Demographic variables include age, race, most serious charge, date of arrest, time of arrest, and education level. The data also include whether the provided urine specimen was positive for several drugs including marijuana, cocaine, PCP, methamphetamines, and barbiturates.
Curated

Arrestee Drug Abuse Monitoring Program II in the United States, 2008 (ICPSR 27221)

Released/updated on: 2010-03-31
Geographic coverage: North Carolina, Oregon, District of Columbia, Charlotte, Sacramento, Indiana, United States, Chicago, Minnesota, California, New York (state), New York City, Minneapolis, Atlanta, Illinois, Colorado, Portland (Oregon), Denver, Georgia, Indianapolis
The Arrestee Drug Abuse Monitoring (ADAM II) program was designed to monitor trends in drug use among arrested populations in key urban areas across the United States. The first ADAM data collection was instituted in 2000 as a replacement for the Drug Use Forecasting program (DUF), which employed a non-scientific sampling procedure to select primarily felony arrestees in 23 urban areas throughout the country. The year 2000 revision of ADAM instituted a representative sampling strategy among booked male arrestees in an expanded network of 35 sites. The program was suspended by the National Institute of Justice in 2003 and restarted in 2007 with funding from the Office of National Drug Control Policy (ONDCP). With ADAM II, ONDCP and its contractor, Abt Associates Inc. have initiated a new data collection that replicates the ADAM methodology in order to obtain data comparable to previously established trends. ADAM II implements two quarters of data collection in ten sentinel ADAM sites to revive monitoring drug trends, with a particular focus on obtaining valid and reliable information on methamphetamine use. Representing minimal adjustments to the previously employed ADAM survey, the ADAM II survey collects data about drug use, drug and alcohol dependency and treatment, and drug market participation among booked male arrestees within 48 hours of arrest. Data collection has been conducted across two back-to-back quarters in each of 10 counties from a county-based representative sample of 250 male arrestees per quarter for a total of 500 arrestees annually per site or a total of 5,000 arrestees across sites annually. A total of 7,717 arrestees were interviewed during the second and third quarters of 2008. Collection occurs in two cycles in booking facilities at each site to provide estimates for two calendar quarters each year. Data in this file were collected beginning April 1, 2007 and ending March 31, 2008. Additional data collection periods were optioned by ONDCP, and subsequent cycles of back-to-back data collection (not yet available) began April 1, 2008. Participation is voluntary and confidential, and the procedures include a personal interview (lasting approximately 20 minutes) and collection of a urine specimen. Demographic variables include age, race, most serious charge, date of arrest, time of arrest, and education level. The data also include whether the provided urine specimen was positive for several drugs including marijuana, cocaine, PCP, methamphetamines, and barbiturates.
Curated

California Drug and Alcohol Treatment Assessment (CALDATA), 1991-1993 (ICPSR 2295)

Released/updated on: 2008-10-07
Geographic coverage: United States, California
Time period: 1991-01-01--1993-01-01
The California Drug and Alcohol Treatment Assessment (CALDATA) was designed to study the costs, benefits, and effectiveness of the state's alcohol and drug treatment infrastructure (recovery services) and specifically to assess (1) the effects of treatment on participant behavior, (2) the costs of treatment, and (3) the economic value of treatment to society. Data were collected on participants (clients) across four types of treatment programs, or modalities: residential, residential "social model," nonmethadone outpatient, and outpatient methadone (detoxification and maintenance). Data were collected in two phases. In Phase 1, treatment records were abstracted for clients who received treatment or were discharged between October 1, 1991, and September 30, 1992. In Phase 2, these clients were located and recruited for a follow-up interview. The CALDATA design and procedures included elements from several national treatment outcome studies including the Drug Services Research Survey (ICPSR 3393), Services Research Outcomes Study (ICPSR 2691), National Treatment Improvement Evaluation Study (ICPSR 2884), and Drug Abuse Treatment Outcome Study (ICPSR 2258). The record abstract was designed to collect identifying and locating information for interview reference during the personal interviewing phase. The abstract also collected demographic, drug, or alcohol use, and treatment and service information. The follow-up questionnaire covered time periods before, during, and after treatment and focused on topics such as ethnic and educational background, drug and alcohol use, mental and physical health, HIV and AIDS status, drug testing, illegal activities and criminal status, living arrangements and family issues, employment and income, and treatment for drug, alcohol, and mental health problems. Drugs included alcohol, barbiturates, benzodiazepines, cocaine powder, crack, downers, hallucinogens, heroin, illegal methadone, inhalants, LSD, marijuana/hashish/THC, methamphetamines and other stimulants, narcotics, over-the-counter drugs, PCP, ritalin or preludin, and sedatives/hypnotics. CALDATA was originally known as the California Outcomes Study (COS).
Curated

Chicago Male Drug Use and Health Survey (MSM Supplement), 2002-2003 (ICPSR 34303)

Released/updated on: 2012-08-01
Geographic coverage: United States, Chicago, Illinois
Time period: 2002-09-01--2003-01-01
In recent years, club drugs such as MDMA, Ketamine, GHB, and Rohypnol have emerged as major drugs of abuse. The national and local Chicago news media have publicized law enforcement actions and adverse health outcomes, including fatalities, related to the abuse of these substances. Media accounts and a limited body of research have identified use of these substances as prevalent in the gay male community. This prevalence coincides with recent increases in HIV seropositive incidence. There is a clear need for a more comprehensive understanding of the prevalence of club drug use in the general population, and particularly in the subgroup of sexually active gay men. Noting these research gaps and their considerable adverse public health implications, this supplemental study was designed to apply an expanded protocol developed from an earlier study conducted (Feasibility and Use of Biological Measurement in Drug Surveys; R01DA12425, SRL Study #860) to a sample of gay men in the city of Chicago (Michael Fendrich, Principal Investigator). This study evaluated whether findings regarding the feasibility and use of drug testing in drug surveys derived from general population samples are generalizable to a probability sample of 216 gay men in the city of Chicago. For this project, a supplemental module was added to the main study survey that asked detailed questions about involvement in the gay community, risky sexual activity and HIV seropositivity. The scope of biological measurement was also expanded to incorporate testing for Rohypnol and Ketamine in hair (MDMA was already being tested as part of the general sample hair screen). The dataset contains 676 variables.
Curated

Crack, Powder Cocaine, and Heroin: Drug Purchase and Use Patterns in Six Cities in the United States, 1995-1996 (ICPSR 2564)

Released/updated on: 2012-08-22
Geographic coverage: New York City, Oregon, District of Columbia, San Diego, San Antonio, United States, Chicago, Illinois, Texas, Portland (Oregon), California, New York (state)
Time period: 1995-01-01--1996-01-01
This study was designed to address the practical and policy implications of various drug market participation patterns. In 1995, the Office of National Drug Control Policy (ONDCP) and the National Institute of Justice (NIJ) collaborated on a project called the Procurement Study. This study was executed as an addendum to NIJ's Drug Use Forecasting (DUF) program (DRUG USE FORECASTING IN 24 CITIES IN THE UNITED STATES, 1987-1997 [ICPSR 9477]) with the goal of extending previous research in which heroin users were interviewed on various aspects of drug market activity. The present study sought to explore additional features of drug market participation and use, both within and across drug types and cities, and included two additional drugs -- powder cocaine and crack cocaine. Data were collected from recently arrested users of powder cocaine, crack cocaine, and heroin in six DUF cities (Chicago, New York, Portland, San Diego, San Antonio, and Washington, DC). Each of the three files in this collection, Crack Data (Part 1), Heroin Data (Part 2), and Powder Cocaine Data (Part 3), is comprised of data from a procurement interview, urine test variables, and a DUF interview. During the procurement interview, information was collected on purchase and use patterns for specific drugs. Variables from the procurement interview include the respondent's method of using the drug, the term used to refer to the drug, whether the respondent bought the drug in the neighborhood, the number of different dealers the respondent bought the drug from, how the respondent made the connection with the dealer (i.e., street, house, phone, beeper, business/store, or friends), their main drug source, whether the respondent went to someone else if the source was not available, how the respondent coped with not being able to find drugs to buy, whether the respondent got the drug for free, the means by which the respondent obtained money, the quantity and packaging of the drug, and the number of minutes spent searching for, traveling to, and waiting for their last purchase. Urine tests screened for the presence of ten drugs, including marijuana, opiates, cocaine, PCP, methadone, benzodiazepines (Valium), methaqualone, propoxyphene (Darvon), barbiturates, and amphetamines (positive test results for amphetamines were confirmed by gas chromatography). Data from the DUF interview provide detailed information about each arrestee's self-reported use of 15 drugs. For each drug type, arrestees were asked whether they had ever used the drug, the age at which they first used the drug, whether they had used the drug within the past three days, how many days they had used the drug within the past month, whether they had ever needed or felt dependent on the drug, and whether they were dependent on the drug at the time of the interview. Data from the DUF interview instrument also included alcohol/drug treatment history, information about whether arrestees had ever injected drugs, and whether they were influenced by drugs when the crime that they were charged with was committed. The data also include information about whether the arrestee had been to an emergency room for drug-related incidents and whether he or she had had prior arrests in the past 12 months. Demographic data include the age, race, sex, educational attainment, marital status, employment status, and living circumstances of each respondent.
Curated

Criminal Justice Drug Abuse Treatment Studies (CJ-DATS): National Criminal Justice Treatment Program (NCJTP) Survey in the United States, 2002-2008 (ICPSR 27382)

Released/updated on: 2010-08-09
Geographic coverage: District of Columbia, United States
Time period: 2002-01-01--2008-01-01
The National Criminal Justice Treatment Practices (NCJTP) Survey provides a comprehensive inquiry into the nature of programs and services provided to adult and juvenile offenders involved in the justice system in the United States. Participants included key criminal justice administrators, operations managers, and staff. This survey was conducted in all 50 states and the District of Columbia. The survey involved a myriad of state, regional, and local organizations employing a mix of their own staff and contracted personnel, and services that might involve multiple levels of government. It was a self-administrated, paper-and-pencil questionnaire. The methodology included a multilevel approach that captured the perspective of executives, front-line administrators, and line staff about current practices in a range of institutional and community correctional settings for adults and juveniles. The goals for this survey were: to describe current drug treatment practices, policies, and delivery systems for offenders on probation or parole supervision, and in jails, prisons, and youth institutions; to examine agency structures, resources, and other organizational factors that may affect service delivery, including mission, leadership, climate, culture, and beliefs about rehabilitation versus punishment; and to assess coordination and integration across criminal justice agencies and between corrections and treatment systems. Items in the survey included: respondent characteristics, organizational characteristics, correctional programs characteristics (e.g., size, nature, etc.), substance abuse treatment programs characteristics, social networks/agencies collaboration, integration of services with other agencies, attitudes toward punishment and rehabilitation (personal values), organizational needs assessment, organizational culture and climate for treatment, cynicism toward change, organizational commitment to treatment, and perspectives on intradepartmental coordination.
Curated
Simple Crosstabs

Development and Malleability from Childhood to Adulthood in Baltimore, Maryland, 2001-2005 (ICPSR 34870)

Released/updated on: 2015-04-27
Geographic coverage: Baltimore, United States, Maryland
Time period: 2001-01-01--2005-01-01

In the fall of 1993, the entering 1st graders in nine Baltimore City, Maryland public elementary schools were recruited for participation in a randomized trial of two universal, preventive interventions. Both interventions targeted the early antecedent risk behaviors of poor academic achievement and aggressive/coercive behavior and their distal correlates: substance abuse/dependence, antisocial behavior, high risk sexual behavior, sexually transmitted infections (STIs), and psychiatric symptoms and disorders. One intervention, the classroom-centered intervention (CC), sought to reduce the early risk behaviors of poor achievement and aggressive/coercive behaviors through the enhancement of classroom curricula and teacher instructional and behavior management practices. The second intervention, the family-school partnership intervention (FSP), sought to reduce these early risk behaviors by improving parent-teacher/school mental health professional collaboration and by enhancing parents' teaching and behavior management skills. The participating students and 1st grade teachers were randomly assigned to either the CC or FSP classroom-level conditions or to a control or standard setting classroom. The participating students' outcomes were assessed from the fall of 1st grade through 12th grade. Annual outcome assessments continued following high school through age ~ 26. Data from participating students' self-report of substance use and its putative mediators and moderators in 8th through 12th grade are available in this dataset.

The principal investigator withheld the intervention status variable that distinguishes the intervention groups from the control group. You may contact the Principal investigator to discuss obtaining the intervention variable.

This dataset contains variables on frequency of respondents' substance use during the respondents' lifetime as well as in the year, month, week prior to the survey. In addition, the dataset contains variables on alcohol consumption. The dataset also contains variables on the respondents' perceptions of the availability and harmfulness of substances. Respondents were also asked about perception of how many of his/her friends used drugs as well as their attitudes towards drug use, including personal disapproval of drug use, and perceived attitudes of parents and friends towards the respondents' drug use. Respondents were asked whether and how often they were offered substances to use and their intention to use substances if offered in the future. Substances asked about include tobacco, alcohol, marijuana, cocaine, crack, heroin, ecstasy, and inhalants.

This dataset contains 1535 variables and 713 respondents. The only demographic variables in this dataset are race and gender.

Curated

Epidemiologic Catchment Area Program Sites 1-4, 1979-1983 with National Death Index Data through 2007 (ICPSR 36621)

Released/updated on: 2017-10-17
Geographic coverage: North Carolina, Baltimore, New Haven, United States, Connecticut, Missouri, St. Louis, Durham, Maryland
Time period: 1979-01-01--1982-01-01, 1980-01-01--1983-01-01, 1979-01-01--2007-01-01

The Epidemiologic Catchment Area (ECA) program of research was initiated in response to the 1977 report of the President's Commission on Mental Health. The purpose was to collect data on the prevalence and incidence of mental disorders and on the use of and need for services by the mentally ill. Independent research teams at five universities (Yale University, Johns Hopkins University, Washington University, Duke University, and University of California at Los Angeles), in collaboration with the National Institute for Mental Health, conducted the studies with a core of common questions and sample characteristics. The sites were areas that had previously been designated as Community Mental Health Center catchment areas: New Haven, Connecticut, Baltimore, Maryland, St. Louis, Missouri, Durham, North Carolina, and Los Angeles, California. Each site sampled over 3,000 community residents and 500 residents of institutions, yielding 20,861 respondents overall. The longitudinal ECA design incorporated two waves of personal interviews administered one year apart and a brief telephone interview in between (for the household sample). The diagnostic interview used in the ECA was the NIMH Diagnostic Interview Schedule (DIS), Version III (with the exception of the Yale Wave I survey, which used Version II). Diagnoses were categorized according to the DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS, 3rd Edition (DSM-III). Diagnoses derived from the DIS include manic episode, dysthymia, bipolar disorder, single episode major depression, recurrent major depression, atypical bipolar disorder, alcohol abuse or dependence, drug abuse or dependence, schizophrenia, schizophreniform, obsessive compulsive disorder, phobia, somatization, panic, antisocial personality, and anorexia nervosa. The DIS uses the Mini-Mental State Examination (MMSE), which measures cognitive functioning, as an indirect measure of the DSM-III Organic Mental Disorders. In the ECA survey, this diagnosis is called cognitive impairment.

This collection features data from 17,327 participants across 2,005 variables. Data from the Los Angeles, California, Catchment (UCLA) are not included. Baseline data (Wave 1) and Wave 2 data were linked to the National Death Index through 2007, which includes primary and contributing causes of death, International Classification of Disease (ICD) codes, and nature of injury variables.

Curated

Estimating the Elasticities of Demand for Cocaine and Heroin with Data from 21 Cities from the Drug Use Forecasting (DUF) Program, 1987-1991 (ICPSR 6567)

Released/updated on: 2006-03-30
Geographic coverage: United States
Time period: 1987-01-01--1991-01-01
The objective of this research was to estimate the elasticity of the demand for cocaine and heroin with respect to the price. Price elasticity is the percentage of change in the dependent quantity corresponding to a one-percent change in price. The project involved the development of an econometric model to determine price elasticity, given that national- and city-level data on the consumption of cocaine and heroin are insufficient or nonexistent. The researchers circumvented this lack of data by partitioning the desired elasticity into the product of two elasticities, involving a measurable intermediate quantity whose relationship to the quantity of consumption could be modeled and estimated by measurable techniques. The intermediate quantity used for this project was the fraction of arrestees testing positive for cocaine or heroin as measured by the Drug Use Forecasting (DUF) System. From the Drug Enforcement Administration's (DEA's) System to Retrieve Information from Drug Evidence (STRIDE) data, expected purity was computed by regressing on log quantity and dummy variables for location and quarter. Price series were produced by finding the median standardized price per expected pure gram for each location and quarter. Variables for Part 1, National Data, include year, quarter, standardized prices for a gram of cocaine and a gram of heroin, and expected purity of cocaine and heroin. The Cities Data, Part 2, cover city, year, quarter, number of observations used to compute the median price of cocaine and heroin, standardized prices, and expected purity.
Curated

Gender, Mental Illness, and Crime in the United States, 2004 (ICPSR 27521)

Released/updated on: 2011-02-10
Geographic coverage: United States
The purpose of the study was to examine the gendered effects of depression, drug use, and treatment on crime and the effects of interaction with the criminal justice system on subsequent depression and drug use. The data for the study are from the NATIONAL HOUSEHOLD SURVEY ON DRUG USE AND HEALTH (NSDUH), 2004 [ICPSR 4373]. In addition to the 2004 NSDUH data, the study utilized new variables that were derived from the original dataset by the principal investigator, namely recoded variables, interaction variables, and computed indices. Information was provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 years and older. Respondents also provided detailed information regarding criminal activity, depression, and other factors. A total of 55,602 respondents participated in the study. The dataset contains a total of 3,011 variables. The first 2,690 variables are drawn from the 2004 NSDUH dataset and the remaining 321 variables were created by the principal investigator. Variables created by the principal investigator are manipulations of the first 2,690 variables. Specifically, these variables include depression indices, drug dependence indicators, interactions with gender and other demographic variables, and dichotomous recoded variables relating to types of drug abuse and criminal behavior.
Curated

Monitoring Drug Epidemics and the Markets That Sustain Them, Arrestee Drug Abuse Monitoring (ADAM) and ADAM II Data, 2000-2003 and 2007-2010 (ICPSR 33201)

Released/updated on: 2012-12-13
Geographic coverage: North Carolina, Oregon, District of Columbia, Charlotte, Sacramento, Indiana, United States, Chicago, Minnesota, California, New York (state), New York City, Minneapolis, Atlanta, Illinois, Colorado, Portland (Oregon), Denver, Georgia, Indianapolis
Time period: 2000-01-01--2003-01-01, 2007-01-01--2010-01-01
This study examined trends in the use of five widely abused drugs among arrestees at 10 geographically diverse locations from 2000 to 2010: Atlanta, Charlotte, Chicago, Denver, Indianapolis, Manhattan, Minneapolis, Portland Oregon, Sacramento, and Washington DC. The data came from the Arrestee Drug Abuse Monitoring Program reintroduced in 2007 (ADAM II) and its predecessor the ADAM program. ADAM data included urinalysis results that provided an objective measure of recent drug use, provided location specific estimates over time, and provided sample weights that yielded unbiased estimates for each location. The ADAM data were analyzed according to a drug epidemics framework, which has been previously employed to understand the decline of the crack epidemic, the growth of marijuana use in the 1990s, and the persistence of heroin use. Similar to other diffusion of innovation processes, drug epidemics tend to follow a natural course passing through four distinct phases: incubation, expansion, plateau, and decline. The study also searched for changes in drug markets over the course of a drug epidemic.
Curated

National Comorbidity Survey: Baseline (NCS-1), 1990-1992 (ICPSR 6693)

Released/updated on: 2008-09-12
Geographic coverage: United States
Time period: 1990-01-01--1992-01-01
The National Comorbidity Survey: Baseline (NCS-1) was a collaborative epidemiologic investigation designed to study the prevalence and correlates of DSM III-R disorders and patterns and correlates of service utilization for these disorders. The NCS-1 was the first survey to administer a structured psychiatric interview to a nationally representative sample. The survey was carried out in the early 1990s with a household sample of over 8,000 respondents. Subsamples of the original respondents completed the NCS-1 Part II survey and Tobacco Use Supplement. Diagnoses were based on a modified version of the Composite International Diagnostic Interview (the UM-CIDI), which was developed at the University of Michigan for the NCS-1. Drugs covered by this survey include alcohol, tobacco, sedatives, stimulants, tranquilizers, analgesics, inhalants, marijuana/hashish, cocaine, hallucinogens, heroin, nonmedical use of prescription drugs, and polysubstance use. Other items include demographic characteristics, personal and family history of substance use and abuse, substance abuse treatment, data on drug use including recency, frequency, and age at first use, problems resulting from the use of drugs, personal and family history of psychiatric problems, mental health treatment, symptoms of psychiatric disorders, mental health status, HIV risk behaviors, and physical health status.
Curated

National Comorbidity Survey: Baseline (NCS-1), 1990-1992 (Restricted Version) (ICPSR 25381)

Released/updated on: 2023-11-06
Geographic coverage: United States
Time period: 1990-01-01--1992-01-01
The National Comorbidity Survey: Baseline (NCS-1) is a collaborative epidemiologic investigation designed to study the prevalence and patterns of disorders in the third and revised edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM III-R) as well as correlates of service utilization for these disorders. The NCS-1 was the first survey to administer a structured psychiatric interview to a nationally representative sample and was carried out in the early 1990s with a household sample of over 8,000 respondents. Diagnoses were based on a modified version of the Composite International Diagnostic Interview (the UM-CIDI), which was developed at the University of Michigan for the NCS-1. This restricted-use data collection contains the following geographic variables that can be linked to the public-use version of the data using the CASEID variable: Census State FIPS codes, Census County FIPS codes, Census 5-Digit County-State FIPS codes, and Census 11-Digit State-County-Tract FIPS codes. However, in order to help preserve the confidentiality of the data the frequency tables in the codebook have been suppressed.
Curated

National Household Survey on Drug Abuse, 1979 (ICPSR 6843)

Released/updated on: 2015-11-23
Geographic coverage: United States
This series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, tobacco, and nonmedical use of prescription drugs among members of United States households aged 12 and older. Questions include age at first use, as well as lifetime, annual, and past-month usage for the following drug classes: cannabis, cocaine, hallucinogens, heroin, inhalants, alcohol, tobacco, nonmedical use of prescription drugs including psychotherapeutics, and polysubstance use. Respondents were also asked about their knowledge of drugs, perceptions of the risks involved, population movement, and sequencing of drug use. Fifty-seven percent of respondents were asked specific questions about their perceptions of the consequences of marijuana and alcohol use. The other 43 percent were asked about heroin use among friends. Demographic data include gender, race, age, ethnicity, marital status, educational level, job status, income level, and household composition.
Curated

National Household Survey on Drug Abuse, 1982 (ICPSR 6845)

Released/updated on: 2015-11-23
Geographic coverage: United States
This series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, tobacco, and nonmedical use of prescription drugs among members of United States households aged 12 and older. Questions include age at first use, as well as lifetime, annual, and past-month usage for the following drug classes: cannabis, cocaine, hallucinogens, heroin, alcohol, tobacco, and nonmedical use of prescription drugs, including psychotherapeutics. Respondents were also asked about problems resulting from their use of drugs, alcohol, and tobacco, their perceptions of the risks involved, and personal and family income sources and amounts. Half of the respondents were asked questions regarding substance use by close friends. Demographic data include gender, race, age, ethnicity, educational level, job status, income level, veteran status, household composition, and population density. Youth respondents were also asked about time spent on homework and leisure activities.
Curated

National Household Survey on Drug Abuse, 1985 (ICPSR 6844)

Released/updated on: 2015-11-23
Geographic coverage: United States
This series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, tobacco, and nonmedical use of prescription drugs among members of United States households aged 12 and older. Questions include age at first use as well as lifetime, annual, and past-month usage for the following drug classes: cannabis, cocaine, hallucinogens, heroin, inhalants, alcohol, tobacco, nonmedical use of prescription drugs including psychotherapeutics, and polysubstance use. Respondents were also asked about health conditions, substance abuse treatment history, problems resulting from their use of drugs, alcohol, and tobacco, their perceptions of the risks involved, and personal and family income sources and amounts. Demographic data include gender, race, age, ethnicity, marital status, motor vehicle use, educational level, job status, income level, veteran status, past and current household composition, and population density.
Curated

National Household Survey on Drug Abuse, 1988 (ICPSR 9522)

Released/updated on: 2013-06-19
Geographic coverage: United States
This series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, anabolic steroids, and tobacco among members of United States households aged 12 and older. Questions include age at first use, as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, inhalants, cocaine, hallucinogens, heroin, alcohol, tobacco, and nonmedical use of psychotherapeutics. Respondents were also asked about problems resulting from their use of drugs, alcohol, and tobacco, their perceptions of the risks involved, insurance coverage, and personal and family income sources and amounts. Demographic data include gender, race, ethnicity, educational level, job status, income level, household composition, and population density.
Curated

National Household Survey on Drug Abuse, 1990 (ICPSR 9833)

Released/updated on: 2013-05-06
Geographic coverage: United States
This series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, anabolic steroids, and tobacco among members of United States households aged 12 and older. Questions include age at first use, as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, inhalants, cocaine, hallucinogens, heroin, alcohol, tobacco, and nonmedical use of psychotherapeutics. Respondents were also asked about problems resulting from their use of drugs, alcohol, and tobacco, their perceptions of the risks involved, insurance coverage, and personal and family income sources and amounts. Demographic data include gender, race, ethnicity, educational level, job status, income level, household composition, and population density.
Curated

National Household Survey on Drug Abuse, 1991 (ICPSR 6128)

Released/updated on: 2015-11-23
Geographic coverage: United States
This series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, anabolic steroids, and tobacco among members of United States households aged 12 and older. Data are also provided on treatment for drug use and on illegal activities related to drug use. Questions include age at first use, as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, inhalants, cocaine, hallucinogens, heroin, alcohol, tobacco, and nonmedical use of psychotherapeutics. Respondents were also asked about problems resulting from their use of drugs, alcohol, and tobacco, their perceptions of the risks involved, insurance coverage, and personal and family income sources and amounts. Demographic data include gender, race, ethnicity, educational level, job status, income level, household composition, and population density.
Curated

National Household Survey on Drug Abuse, 1992 (ICPSR 6887)

Released/updated on: 2013-05-06
Geographic coverage: United States
This series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, anabolic steroids, and tobacco among members of United States households aged 12 and older. Data are also provided on treatment for drug use and on illegal activities related to drug use. Questions include age at first use, as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, inhalants, cocaine, hallucinogens, heroin, alcohol, tobacco, and nonmedical use of psychotherapeutics. Respondents were also asked about problems resulting from their use of drugs, alcohol, and tobacco, their perceptions of the risks involved, insurance coverage, and personal and family income sources and amounts. Demographic data include gender, race, ethnicity, educational level, job status, income level, household composition, and population density.
Curated

National Household Survey on Drug Abuse, 1993 (ICPSR 6852)

Released/updated on: 2013-05-06
Geographic coverage: United States
This series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, anabolic steroids, and tobacco among members of United States households aged 12 and older. Data are also provided on treatment for drug use and on illegal activities related to drug use. Questions include age at first use, as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, inhalants, cocaine, hallucinogens, heroin, alcohol, tobacco, and nonmedical use of psychotherapeutics. Respondents were also asked about problems resulting from their use of drugs, alcohol, and tobacco, their perceptions of the risks involved, insurance coverage, and personal and family income sources and amounts. Demographic data include gender, race, ethnicity, educational level, job status, income level, household composition, and population density.
Curated

National Household Survey on Drug Abuse, 1994 (ICPSR 6949)

Released/updated on: 2013-06-20
Geographic coverage: United States
This series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions include age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, anabolic steroids, nonmedical use of prescription-type psychotherapeutic drugs, and polysubstance use. Respondents were also asked about substance abuse treatment history, illegal activities, problems resulting from use of drugs, perceptions of the risks involved, and personal and family income sources and amounts. Questions on need for treatment for drug or alcohol use, criminal record, and needle-sharing were also included. A split sample design using two questionnaires was employed with the 1994 NHSDA. The 1994-A questionnaire is comparable to NHSDA questionnaires prior to 1994 and contains all of the core questions from previous NHSDAs. The 1994-B questionnaire, which includes new questions on access to care and mental health, incorporates significant changes from the previous questionnaires and can only be compared to NHSDA surveys in 1995 and beyond. The changes to the questionnaire were undertaken in order to facilitate respondent cooperation, enhance the clarity of questions, improve the accuracy of responses, and increase the reliability of measurements across survey years. In addition, a rural supplementary sample was included in 1994 to obtain substance abuse prevalence estimates for rural areas. Demographic data include gender, race, age, ethnicity, marital status, motor vehicle use, educational level, job status, income level, veteran status, and past and current household composition.
Curated

National Household Survey on Drug Abuse, 1995 (ICPSR 6950)

Released/updated on: 2013-05-06
Geographic coverage: United States
This series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions include age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, anabolic steroids, nonmedical use of prescription drugs including psychotherapeutics, and polysubstance use. Respondents were also asked about substance abuse treatment history, illegal activities, problems resulting from use of drugs, perceptions of the risks involved, personal and family income sources and amounts, need for treatment for drug or alcohol use, criminal record, and needle-sharing. Questions on mental health and access to care, which were introduced in the 1994-B questionnaire (see NATIONAL HOUSEHOLD SURVEY ON DRUG ABUSE, 1994 [ICPSR 6949]), were retained in this administration of the survey. Demographic data include gender, race, age, ethnicity, marital status, motor vehicle use, educational level, job status, income level, veteran status, and past and current household composition.
Curated

National Household Survey on Drug Abuse, 1996 (ICPSR 2391)

Released/updated on: 2013-05-06
Geographic coverage: United States
This series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions include age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including psychotherapeutics. Respondents were also asked about substance abuse treatment history, illegal activities, problems resulting from the use of drugs, personal and family income sources and amounts, need for treatment for drug or alcohol use, criminal record, and needle-sharing. Questions on mental health and access to care, which were introduced in the 1994-B questionnaire (see NATIONAL HOUSEHOLD SURVEY ON DRUG ABUSE, 1994 [ICPSR 6949]), were retained in this administration of the survey. In 1996, the section on risk/availability of drugs was reintroduced, and sections on driving behavior and personal behavior were added. Demographic data include gender, race, age, ethnicity, marital status, educational level, job status, income level, veteran status, and current household composition.
Curated

National Household Survey on Drug Abuse, 1997 (ICPSR 2755)

Released/updated on: 2013-05-06
Geographic coverage: United States
This series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions include age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including psychotherapeutics. Respondents were also asked about substance abuse treatment history, illegal activities, problems resulting from the use of drugs, personal and family income sources and amounts, need for treatment for drug or alcohol use, criminal record, and needle-sharing. Questions on mental health and access to care, which were introduced in the 1994-B questionnaire (see NATIONAL HOUSEHOLD SURVEY ON DRUG ABUSE, 1994 [ICPSR 6949]), were retained in this administration of the survey. In 1996, the section on risk/availability of drugs was reintroduced, and sections on driving behavior and personal behavior were added (see NATIONAL HOUSEHOLD SURVEY ON DRUG ABUSE, 1996 [ICPSR 2391]). The 1997 questionnaire continued the risk/availability section along with new items about the use of cigars, people present when respondents used marijuana or cocaine for the first time (if applicable), reasons for using these two drugs the first time, reasons for using these two drugs in the past year, reasons for discontinuing use of these two drugs (for lifetime but not past-year users), and reasons respondents never used these two drugs. In addition, a new series of questions asked only of respondents aged 12 to 17 was introduced. These items covered a variety of topics that may be associated with substance use and related behaviors, such as exposure to substance abuse prevention and education programs, gang involvement, relationship with parents, and substance use by friends. Demographic data include gender, race, age, ethnicity, marital status, educational level, job status, income level, veteran status, and current household composition.
Curated

National Household Survey on Drug Abuse, 1998 (ICPSR 2934)

Released/updated on: 2013-05-06
Geographic coverage: United States
The National Household Survey on Drug Abuse (NHSDA) series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions include age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including psychotherapeutics. Respondents were also asked about personal and family income sources and amounts, substance abuse treatment history, illegal activities, problems resulting from the use of drugs, need for treatment for drug or alcohol use, criminal record, and needle-sharing. Questions on mental health and access to care, which were introduced in the 1994-B questionnaire (see NATIONAL HOUSEHOLD SURVEY ON DRUG ABUSE, 1994 [ICPSR 6949]), were retained in this administration of the survey. Also retained was the section on risk/availability of drugs that was reintroduced in 1996, and sections on driving behavior and personal behavior were added (see NATIONAL HOUSEHOLD SURVEY ON DRUG ABUSE, 1996 [ICPSR 2391]). The 1997 questionnaire (NATIONAL HOUSEHOLD SURVEY ON DRUG ABUSE, 1997 [ICPSR 2755]) introduced new items that the 1998 NHSDA continued on cigar smoking, people who were present when respondents used marijuana or cocaine for the first time (if applicable), reasons for using these two drugs the first time, reasons for using these two drugs in the past year, reasons for discontinuing use of these two drugs (for lifetime but not past-year users), and reasons respondents never used these two drugs. Both the 1997 and 1998 NHSDAs had a series of questions that were asked only of respondents aged 12 to 17. These items covered a variety of topics that may be associated with substance use and related behaviors, such as exposure to substance abuse prevention and education programs, gang involvement, relationship with parents, and substance use by friends. Demographic data include gender, race, age, ethnicity, marital status, educational level, job status, income level, veteran status, and current household composition.
Curated

National Household Survey on Drug Abuse, 1999 (ICPSR 3239)

Released/updated on: 2013-06-25
Geographic coverage: United States
The National Household Survey on Drug Abuse (NHSDA) series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions include age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covers substance abuse treatment history and perceived need for treatment, and includes questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. Respondents are also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous NHSDA administrations were retained in the 1999 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, gang involvement, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving behavior and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. Demographic data include gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition.
Curated

National Household Survey on Drug Abuse, 2000 (ICPSR 3262)

Released/updated on: 2013-06-25
Geographic coverage: United States
The National Household Survey on Drug Abuse (NHSDA) series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions include age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covers substance abuse treatment history and perceived need for treatment, and includes questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. Respondents are also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous NHSDA administrations were retained in the 2000 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, gang involvement, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving behavior and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey and retained in the 2000 survey. Demographic data include gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition.
Curated

National Household Survey on Drug Abuse, 2001 (ICPSR 3580)

Released/updated on: 2013-06-25
Geographic coverage: United States
The National Household Survey on Drug Abuse (NHSDA) series measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions include age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covers substance abuse treatment history and perceived need for treatment, and includes questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. Respondents are also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous NHSDA administrations were retained in the 2001 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, gang involvement, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving behavior and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey and have been retained through the 2001 survey. Demographic data include gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition. In addition, in 2001 questions on purchase of marijuana were added.
Curated

National Pregnancy and Health Survey: Drug Use Among Women Delivering Live Births, 1992 (ICPSR 2835)

Released/updated on: 2008-07-31
Geographic coverage: United States
Time period: 1992-01-01--1993-01-01
The primary objective of the National Pregnancy and Health Survey (NPHS) was to produce national annual estimates of the percentages and numbers of mothers of live newborns in the United States who used selected licit and illicit drugs in the 12 months prior to delivery. A further objective was to describe patterns of prenatal substance use among demographic subgroups of women. Information on demographic and socioeconomic characteristics, obstetric history, and drug treatment of women who delivered infants at sampled hospitals was obtained through an interviewer-administered questionnaire, while data on substance use before and during pregnancy were collected through a questionnaire completed by the respondent and concealed from the interviewer. Respondents were asked about use of the following substances: alcohol, amphetamines, analgesics, cocaine, crack cocaine, barbiturates, hallucinogens, hashish, heroin, marijuana, methadone, methamphetamine, sedatives, stimulants, tobacco, and tranquilizers. Additionally, information was collected on the respondent's pregnancy, prenatal care, delivery, previous pregnancies, and background. Additional data were obtained from the mothers' and infants' medical records. Urine specimens collected routinely by the hospital on obstetric admissions were tested for selected drugs. Finally, in a subsample of six hospitals, hair specimens were requested from respondents to evaluate the potential of hair as a source of toxicological data in future studies.
Curated
Simple Crosstabs

National Survey on Drug Use and Health, 2002 (ICPSR 3903)

Released/updated on: 2015-11-23
Geographic coverage: United States
The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions include age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covers substance abuse treatment history and perceived need for treatment, and includes questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey includes questions concerning treatment for both substance abuse and mental health related disorders. Respondents are also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2002 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, gang involvement, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey and have been retained through the 2002 survey. Demographic data include gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition.
Curated
Simple Crosstabs

National Survey on Drug Use and Health, 2003 (ICPSR 4138)

Released/updated on: 2015-11-23
Geographic coverage: United States
The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2003 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, gang involvement, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey and retained through the 2003 survey. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition. A number of additional questions were added in 2003, including questions on prior marijuana and cigarette use, additional questions on drug treatment, adult mental health services, and social environment.
Curated
Simple Crosstabs

National Survey on Drug Use and Health, 2004 (ICPSR 4373)

Released/updated on: 2015-11-23
Geographic coverage: United States
The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2004 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey and retained through the 2003 survey. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition. In addition, in 2004 Adult and Adolescent Mental Health modules were added.
Curated
Simple Crosstabs

National Survey on Drug Use and Health, 2005 (ICPSR 4596)

Released/updated on: 2015-11-23
Geographic coverage: United States
The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2005 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition.
Curated
Simple Crosstabs

National Survey on Drug Use and Health, 2006 (ICPSR 21240)

Released/updated on: 2013-06-21
Geographic coverage: United States
The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2006 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition.
Curated
Simple Crosstabs

National Survey on Drug Use and Health, 2007 (ICPSR 23782)

Released/updated on: 2015-11-23
Geographic coverage: United States
The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2007 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition.
Curated
Simple Crosstabs

National Survey on Drug Use and Health, 2008 (ICPSR 26701)

Released/updated on: 2015-11-23
Geographic coverage: United States

The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. Detailed NSDUH 2008 documentation is available from SAMHSA. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2008 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. For this 2008 survey, Adult mental health questions were added to measure symptoms of psychological distress in the worst period of distress that a person experienced in the past 30 days and suicidal ideation. A split-sample design also was included to administer separate sets of questions to assess impairment due to mental health problems. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition.

Curated
Simple Crosstabs

National Survey on Drug Use and Health, 2009 (ICPSR 29621)

Released/updated on: 2015-11-23
Geographic coverage: United States
The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health-related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2009 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. For the 2008 survey, Adult mental health questions were added to measure symptoms of psychological distress in the worst period of distress that a person experienced in the past 30 days and suicidal ideation. In 2008, a split-sample design also was included to administer separate sets of questions (WHODAS vs. SDS) to assess impairment due to mental health problems. In the 2009 NSDUH, however, all of the adults in the sample received only the WHODAS questions. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition.
Curated
Simple Crosstabs

National Survey on Drug Use and Health, 2010 (ICPSR 32722)

Released/updated on: 2015-11-23
Geographic coverage: United States
The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health-related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2010 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. For the 2008 survey, adult mental health questions were added to measure symptoms of psychological distress in the worst period of distress that a person experienced in the past 30 days and suicidal ideation. In 2008, a split-sample design also was included to administer separate sets of questions (WHODAS vs. SDS) to assess impairment due to mental health problems. Beginning with the 2009 NSDUH, however, all of the adults in the sample received only the WHODAS questions. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition.
Curated
Simple Crosstabs

National Survey on Drug Use and Health, 2011 (ICPSR 34481)

Released/updated on: 2015-11-23
Geographic coverage: United States
The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health-related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2011 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. For the 2008 survey, adult mental health questions were added to measure symptoms of psychological distress in the worst period of distress that a person experienced in the past 30 days and suicidal ideation. In 2008, a split-sample design also was included to administer separate sets of questions (WHODAS vs. SDS) to assess impairment due to mental health problems. Beginning with the 2009 NSDUH, however, all of the adults in the sample received only the WHODAS questions. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition.
Curated
Simple Crosstabs

National Survey on Drug Use and Health, 2012 (ICPSR 34933)

Released/updated on: 2015-11-23
Geographic coverage: United States
The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health-related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2012 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. For the 2008 survey, adult mental health questions were added to measure symptoms of psychological distress in the worst period of distress that a person experienced in the past 30 days and suicidal ideation. In 2008, a split-sample design also was included to administer separate sets of questions (WHODAS vs. SDS) to assess impairment due to mental health problems. Beginning with the 2009 NSDUH, however, all of the adults in the sample received only the WHODAS questions. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition.
Curated
Simple Crosstabs

National Survey on Drug Use and Health, 2013 (ICPSR 35509)

Released/updated on: 2015-11-23
Geographic coverage: United States
The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health-related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2013 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. For the 2008 survey, adult mental health questions were added to measure symptoms of psychological distress in the worst period of distress that a person experienced in the past 30 days and suicidal ideation. In 2008, a split-sample design also was included to administer separate sets of questions (WHODAS vs. SDS) to assess impairment due to mental health problems. Beginning with the 2009 NSDUH, however, all of the adults in the sample received only the WHODAS questions. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition.
Curated
Simple Crosstabs

National Survey on Drug Use and Health, 2014 (ICPSR 36361)

Released/updated on: 2016-03-22
Geographic coverage: United States
The National Survey on Drug Use and Health (NSDUH) series (formerly titled National Household Survey on Drug Abuse) primarily measures the prevalence and correlates of drug use in the United States. The surveys are designed to provide quarterly, as well as annual, estimates. Information is provided on the use of illicit drugs, alcohol, and tobacco among members of United States households aged 12 and older. Questions included age at first use as well as lifetime, annual, and past-month usage for the following drug classes: marijuana, cocaine (and crack), hallucinogens, heroin, inhalants, alcohol, tobacco, and nonmedical use of prescription drugs, including pain relievers, tranquilizers, stimulants, and sedatives. The survey covered substance abuse treatment history and perceived need for treatment, and included questions from the Diagnostic and Statistical Manual (DSM) of Mental Disorders that allow diagnostic criteria to be applied. The survey included questions concerning treatment for both substance abuse and mental health-related disorders. Respondents were also asked about personal and family income sources and amounts, health care access and coverage, illegal activities and arrest record, problems resulting from the use of drugs, and needle-sharing. Questions introduced in previous administrations were retained in the 2014 survey, including questions asked only of respondents aged 12 to 17. These "youth experiences" items covered a variety of topics, such as neighborhood environment, illegal activities, drug use by friends, social support, extracurricular activities, exposure to substance abuse prevention and education programs, and perceived adult attitudes toward drug use and activities such as school work. Several measures focused on prevention-related themes in this section. Also retained were questions on mental health and access to care, perceived risk of using drugs, perceived availability of drugs, driving and personal behavior, and cigar smoking. Questions on the tobacco brand used most often were introduced with the 1999 survey. For the 2008 survey, adult mental health questions were added to measure symptoms of psychological distress in the worst period of distress that a person experienced in the past 30 days and suicidal ideation. In 2008, a split-sample design also was included to administer separate sets of questions (WHODAS vs. SDS) to assess impairment due to mental health problems. Beginning with the 2009 NSDUH, however, all of the adults in the sample received only the WHODAS questions. Background information includes gender, race, age, ethnicity, marital status, educational level, job status, veteran status, and current household composition.
Curated

Network for the Improvement of Addiction Treatment (NIATx), 2003-2007 (ICPSR 34406)

Released/updated on: 2012-10-17
Geographic coverage: United States
Time period: 2003-01-01--2007-01-01

The Network for the Improvement of Addiction Treatment (NIATx) is a program funded by the Robert Wood Johnson Foundation and the Center for Substance Abuse Treatment to help substance abuse treatment facilities improve the effectiveness and efficiency of care offered to clients. A total of 38 facilities from across the country were awarded funding to implement the NIATx program between the years of 2003 to 2007. Data were extracted from administrative records from 82,274 clients. The data file covers the dates of contact and treatment with the facility, the number of follow-up units of care received, the primary substance of abuse, and basic demographic information.

Curated
Simple Crosstabs

PACARDO: Data on Drug Use and Behavior in School-Aged Children and Teenagers in Panama, Central America, and the Dominican Republic, 1999-2000 (ICPSR 34829)

Released/updated on: 2014-08-05
Geographic coverage: Central America, Nicaragua, El Salvador, Panama, Dominican Republic, Guatemala, Honduras, Costa Rica
Time period: 1999-01-01--2000-01-01
The PACARDO study, concatenated to combine Panamá (PA), Centroamérica (CA), and República Dominicana (RDO), was a multi-national collaborative epidemiological research study whose primary objective was to record and describe self-reported drug use and behavior patterns among school-aged youths in Latin America. During 1999-2000, anonymous self-administered questionnaires on drug involvement and related behaviors were administered to a cross-sectional, nationally representative sample that included a total of 12,797 students in the following seven countries: Costa Rica (n = 1,702), the Dominican Republic (n = 2,023), El Salvador (n = 1,628), Guatemala (n = 2,530), Honduras (n = 1,752), Nicaragua (n = 1,419), and Panama (n = 1,743). Estimates for exposure opportunity and actual use of alcohol, tobacco, inhalants, marijuana, cocaine (crack / cocoa paste), amphetamines and methamphetamines, tranquilizers, ecstasy, and heroin were assessed via responses about questions on age of first chance to try each drug, and first use.
Curated

Project on Human Development in Chicago Neighborhoods (PHDCN): Consequences of Substance Use, Wave 3, 2000-2002 (ICPSR 13687)

Released/updated on: 2007-02-06
Geographic coverage: United States, Chicago, Illinois
Time period: 2000-01-01--2002-01-01
The Project on Human Development in Chicago Neighborhoods (PHDCN) was a large-scale, interdisciplinary study of how families, schools, and neighborhoods affect child and adolescent development. One component of the PHDCN was the Longitudinal Cohort Study, which was a series of coordinated longitudinal studies that followed over 6,000 randomly selected children, adolescents, and young adults, and their primary caregivers over time to examine the changing circumstances of their lives, as well as the personal characteristics, that might lead them toward or away from a variety of antisocial behaviors. Numerous measures were administered to respondents to gauge various aspects of human development, including individual differences, as well as family, peer, and school influences. One such measure was the Consequences of Substance Use interview. It was administered to subjects in Cohorts 9, 12, 15, and 18 and obtained information related to outcomes of the subject being caught, by school officials, police, or their parents, using alcohol or drugs. Subjects in Cohorts 15 and 18 were asked questions from a slightly different instrument than subjects in Cohorts 9 and 12. Cohorts 15 and 18 were asked more detailed questions regarding what substances and what quantity subjects were caught with.
Curated

Project on Human Development in Chicago Neighborhoods (PHDCN): Drug Use, Wave 3, 2000-2002 (ICPSR 13694)

Released/updated on: 2007-02-06
Geographic coverage: United States, Chicago, Illinois
Time period: 2000-01-01--2002-01-01
The Project on Human Development in Chicago Neighborhoods (PHDCN) was a large-scale, interdisciplinary study of how families, schools, and neighborhoods affect child and adolescent development. One component of the PHDCN was the Longitudinal Cohort Study, which was a series of coordinated longitudinal studies that followed over 6,000 randomly selected children, adolescents, and young adults, and their primary caregivers over time to examine the changing circumstances of their lives, as well as the personal characteristics, that might lead them toward or away from a variety of antisocial behaviors. Numerous measures were administered to respondents to gauge various aspects of human development, including individual differences, as well as family, peer, and school influences. One such measure was the Drug Use instrument. It was administered to subjects in Cohorts 0, 3, 6, 9, 12, and 15 and was a self-report measure used to obtain information regarding the subject's use of specific drugs without a doctor's prescription, in larger amounts than prescribed, or for a longer period than prescribed.
Curated

Project on Human Development in Chicago Neighborhoods (PHDCN): Perceptions of Drug Risk, Wave 2, 1997-2000 (ICPSR 13643)

Released/updated on: 2006-04-24
Geographic coverage: United States, Chicago, Illinois
Time period: 1997-01-01--2000-01-01
The Project on Human Development in Chicago Neighborhoods (PHDCN) was a large-scale, interdisciplinary study of how families, schools, and neighborhoods affect child and adolescent development. One component of the PHDCN was the Longitudinal Cohort Study, which was a series of coordinated longitudinal studies that followed over 6,000 randomly selected children, adolescents, and young adults, and their primary caregivers over time to examine the changing circumstances of their lives, as well as the personal characteristics, that might lead them toward or away from a variety of antisocial behaviors. Numerous measures were administered to respondents to gauge various aspects of human development, including individual differences, as well as family, peer, and school influences. One such measure was the Perceptions of Drug Risk instrument. This instrument obtained information about the perceived harm in using substances, the difficulty of obtaining substances, and the experience of being approached to buy drugs. It was administered to Cohorts 9, 12, 15, and 18.
Curated

Project on Human Development in Chicago Neighborhoods (PHDCN): Perceptions of Drug Risk, Wave 3, 2000-2002 (ICPSR 13728)

Released/updated on: 2007-02-06
Geographic coverage: United States, Chicago, Illinois
Time period: 2000-01-01--2002-01-01
The Project on Human Development in Chicago Neighborhoods (PHDCN) was a large-scale, interdisciplinary study of how families, schools, and neighborhoods affect child and adolescent development. One component of the PHDCN was the Longitudinal Cohort Study, which was a series of coordinated longitudinal studies that followed over 6,000 randomly selected children, adolescents, and young adults, and their primary caregivers over time to examine the changing circumstances of their lives, as well as the personal characteristics, that might lead them toward or away from a variety of antisocial behaviors. Numerous measures were administered to respondents to gauge various aspects of human development, including individual differences, as well as family, peer, and school influences. One such measure was the Perceptions of Drug Risk instrument. This instrument obtained information about the perceived harm in using substances, the difficulty of obtaining substances, and the experience of being approached to buy drugs. It was administered to Cohorts 6, 9, and 12. It is closely related to PROJECT ON HUMAN DEVELOPMENT IN CHICAGO NEIGHBORHOODS (PHDCN): PERCEPTIONS OF DRUG RISK, WAVE 2, 1997-2000 (ICPSR 13643).
Curated

Project on Human Development in Chicago Neighborhoods (PHDCN): Substance Use Follow-Up, Wave 3, 2000-2002 (ICPSR 13744)

Released/updated on: 2007-02-07
Geographic coverage: United States, Chicago, Illinois
Time period: 2000-01-01--2002-01-01
The Project on Human Development in Chicago Neighborhoods (PHDCN) was a large-scale, interdisciplinary study of how families, schools, and neighborhoods affect child and adolescent development. One component of the PHDCN was the Longitudinal Cohort Study, which was a series of coordinated longitudinal studies that followed over 6,000 randomly selected children, adolescents, and young adults, and their primary caregivers over time to examine the changing circumstances of their lives, as well as the personal characteristics, that might lead them toward or away from a variety of antisocial behaviors. Numerous measures were administered to respondents to gauge various aspects of human development, including individual differences, as well as family, peer, and school influences. One such measure was the Substance Use Follow-Up instrument. It was adapted from the Composite International Diagnostic Interview (CIDI) and was administered to subjects in Cohorts 15 and 18. It obtained information regarding the subject's use of specific drugs. It is closely related to PROJECT ON HUMAN DEVELOPMENT IN CHICAGO NEIGHBORHOODS (PHDCN): SUBSTANCE USE, WAVE 1, 1994-1997 (ICPSR 13602), PROJECT ON HUMAN DEVELOPMENT IN CHICAGO NEIGHBORHOODS (PHDCN): SUBSTANCE USE, WAVE 2, 1997-2000 (ICPSR 13659), and PROJECT ON HUMAN DEVELOPMENT IN CHICAGO NEIGHBORHOODS (PHDCN): SUBSTANCE USE, WAVE 3, 2000-2002 (ICPSR 13743).
Back to top